Advertisement

Rheumatism and Rheumatic Ophthalmology from the Prospective of Integrative Medicine

  • Zhengang Wang
  • Ying Hong
Chapter
Part of the Advances in Visual Science and Eye Diseases book series (AVSED, volume 3)

Abstract

Rheumatic diseases are complex diseases involving systemic connective tissues. Although the manifestations of rheumatic diseases in joints, muscles, and other motor system have been well known, the ophthalmologists’ awareness of rheumatic ocular disease is still inadequate. Rheumatic ophthalmopathy often becomes a disease difficult to diagnose that confuses clinicians, those who might neglect the screen of systemic diseases, thus leading to misdiagnosis and missed diagnosis. Therefore, the diagnosis and treatment of rheumatic ocular disease need to be combined with the concept of integrative medicine starting from the understanding of systemic diseases. The section introduces the relationship between rheumatism-caused systemic disease and ocular diseases; classification, clinical manifestations, and differential diagnosis of rheumatic ocular diseases; and treatment of systemic diseases. Thus ophthalmologists can understand and attach importance to ocular damage resulting from rheumatism, clear about the clinical manifestations of rheumatic diseases and rheumatic ocular diseases, clarify the etiology timely, and cooperate with rheumatologists, and thus then it would lead to treatment for the “disease,” rather than “symptoms.” At the same time, the section indicates the establishment of the concept for the interdisciplinary cooperative treatment of ophthalmology and rheumatic department for rheumatic ocular diseases, and discusses the possibility of developing specialized clinic for rheumatic ocular diseases, and standardized system for the diagnosis and treatment of rheumatic ocular diseases.

References

  1. 1.
    Peizeng Y. Classifications of uveitis. Beijing: People’s Medical Publishing House; 2004.Google Scholar
  2. 2.
    Gabriel SE. KELLEY’S textbook of rheumatology (Chinese version). Translated by Li Zhanguo, Tang Fulin. Beijing: Peking University Medical Press; 2011.Google Scholar
  3. 3.
    Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68:777–83.CrossRefPubMedGoogle Scholar
  4. 4.
    Criteria for diagnosis of Behçet’s disease. International Study Group for Behçet’s Disease. Lancet. 1990;335:1078–980.Google Scholar
  5. 5.
    Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–8.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Michet CJ Jr, McKenna CH, Luthra HS, et al. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med. 1986;104:74–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Wu IB, Schwartz RA. Reiter’s syndrome: the classic triad and more. J Am Acad Dermatol. 2008;59:113–21.CrossRefPubMedGoogle Scholar
  9. 9.
    Mohsenin A, Huang JJ. Ocular manifestations of systemic inflammatory diseases. Conn Med. 2012;76:533–44.PubMedGoogle Scholar
  10. 10.
    Rothschild PR, Pagnoux C, Seror R, et al. Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a retrospective study of 1286 patients and review of the literature. Semin Arthritis Rheum. 2013;42:507–14.CrossRefPubMedGoogle Scholar
  11. 11.
    Edelsten C, Lee V, Bentley CR, et al. evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol. 2002;86:51–6.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Jasse L, Vukusic S, Durand-Dubief F, et al. Persistent visual impairment in multiple sclerosis: prevalence, mechanisms and resulting disability. Mult Scler. 2013;19:1618–26.CrossRefPubMedGoogle Scholar
  13. 13.
    Liozon E, Ly KH, Robert PY. Ocular complications of giant cell arteritis. Rev Med Interne. 2013;34:421–30.CrossRefPubMedGoogle Scholar
  14. 14.
    Zhengang W. Selected cases of eye & ENT involved in rheumatic diseases. Beijing: People’s Medical Publishing House Co., Ltd.; 2012.Google Scholar
  15. 15.
    Horai R, Caspi RR. Cytokines in autoimmune uveitis. J Interf Cytokine Res. 2011;31:733–44.CrossRefGoogle Scholar
  16. 16.
    McCluskey P, Powell RJ. The eye in systemic inflammatory diseases. Lancet. 2004;364:2125–33.CrossRefPubMedGoogle Scholar
  17. 17.
    Menezo V, Lightman S. The eye in systemic vasculitis. Clin Med. 2004;4:250–4.CrossRefGoogle Scholar
  18. 18.
    Shepherd JB 3rd. Ocular vasculitis. Curr Rheumatol Rep. 2003;5:100–6.CrossRefPubMedGoogle Scholar
  19. 19.
    Herbort CP, Cimino L, Abu El Asrar AM, et al. Ocular vasculitis: a multidisciplinary approach. Curr Opin Rheumatol. 2005;17:25–33.CrossRefPubMedGoogle Scholar
  20. 20.
    Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthritis Rheum. 1994;37:187–92.CrossRefPubMedGoogle Scholar
  21. 21.
    Jennette JC. Overview of the 2012 revised International Chapel Hill Consensus. Clin Exp Nephrol. 2013;17:603–6.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Barisani-Asenbauer T, Maca SM, Mejdoubi L, et al. Uveitis a rare disease often associated with systemic diseases and infections—a systematic review of 2619 patients. Orphanet J Rare Dis. 2012;7:57–64.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Bao T, Yang Z, Zhouying Q. Comparison and analysis of data obtained in two national sampling surveys of disability. Chin J Spec Educ. 2007;8:54–6.Google Scholar
  24. 24.
    Saeki Y, Matsui T, Saisho K, et al. Current treatments of rheumatoid arthritis: from the ‘NinJa’ registry. Expert Rev Clin Immunol. 2012;8:455–65.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. and People's Medical Publishing House, PR of China 2020

Authors and Affiliations

  • Zhengang Wang
    • 1
  • Ying Hong
    • 2
  1. 1.Department of RheumatologyBeijing Tongren Hospital, Capital Medical UniversityBeijingChina
  2. 2.Department of OphthalmologyPeking University Third HospitalBeijingChina

Personalised recommendations